頭蓋内動脈瘤市場：タイプ、適応症、エンドユーザー別-2025-2030年の世界予測

頭蓋内動脈瘤市場は、2023年に13億2,000万米ドルと評価され、2024年には16億米ドルに達すると予測され、CAGR 22.16％で成長し、2030年には53億8,000万米ドルに達すると予測されています。

頭蓋内動脈瘤は脳内の動脈の異常な拡張を指し、潜在的な破裂による重大な健康リスクをもたらし、出血性脳卒中などの重篤な合併症を引き起こします。高血圧、喫煙、アルコール依存症などの生活習慣関連因子の増加により、高度な診断・治療ソリューションの必要性が高まっています。神経画像技術や低侵襲手術技術の革新により、頭蓋内動脈瘤市場は拡大しています。主な用途はヘルスケア分野、特に神経診断センターと病院で、血管内コイリングと流路転換ステントに重点が置かれています。最終用途の観点からは、ヘルスケアプロバイダー、研究機関、機器メーカーが主要な利害関係者となります。市場成長は、技術の進歩、ヘルスケア支出の増加、新興国におけるヘルスケアサービスへのアクセス拡大から大きな影響を受けています。さらに、血管障害の有病率が高い世界人口の高齢化は、さらなる成長の可能性を示しています。しかし、治療費の高騰、規制当局の厳しい承認、未発達地域における認知度の低さといった課題は、市場の拡大を妨げる可能性があります。新たな機会を捉えるには、企業は研究開発に投資して費用対効果の高い効率的な治療法を開発し、医療機関と提携して臨床試験や教育イニシアチブを行う必要があります。最新のビジネスチャンスは、精密医療を強化できるAI主導の診断ツールや患者別の治療計画の台頭にあります。とはいえ、低所得地域における経済的制約や開発コストの高さは、依然として大きなハードルとなっています。革新的な研究分野としては、生分解性ステントの開発、早期発見のためのバイオインフォマティクスの強化、ハイブリッド画像技術などが挙げられます。市場は主に技術的進歩と戦略的提携によって牽引されているため、戦略的提携における積極的なアプローチと、変化する市場力学と患者のニーズに対応するための継続的な技術革新が必要です。

市場力学：急速に進化する頭蓋内動脈瘤市場の主要市場インサイトを公開

頭蓋内動脈瘤市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • ライフスタイルの変化による脳血管障害の有病率の上昇
  • 低侵襲手術への傾斜
  • 頭蓋内動脈瘤の診断の向上
• 市場抑制要因
  • 治療に伴う副作用と治療費の高騰
• 市場機会
  • 研究開発活動の活発化と革新的技術製品のイントロダクション
  • 血管内コイリングの可能性の高まり
• 市場の課題
  • 手術と麻酔導入のタイミングに関する問題

ポーターの5つの力：頭蓋内動脈瘤市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：頭蓋内動脈瘤市場における外部からの影響の把握

外部マクロ環境要因は、頭蓋内動脈瘤市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析頭蓋内動脈瘤市場における競合情勢の把握

頭蓋内動脈瘤市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス頭蓋内動脈瘤市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、頭蓋内動脈瘤市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 生活習慣の変化による脳血管障害の罹患率の上昇
    • 低侵襲頭蓋内動脈瘤処置の傾向
    • 頭蓋内動脈瘤の診断の改善
  • 抑制要因
    • 治療に伴う副作用と治療費の高騰
  • 機会
    • 研究開発活動の活発化と革新的技術製品のイントロダクション
    • 血管内コイル塞栓術の可能性の高まり
  • 課題
    • 手術と麻酔導入のタイミングに関する問題
• 市場セグメンテーション分析
  • タイプ：より小さな嚢状動脈瘤に対する血管内コイル塞栓術などの低侵襲技術の需要
  • エンドユーザー：早期スクリーニングおよび診断サービスを求めるクリニック間の患者流入の増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境
• 顧客のカスタマイズ

第6章 頭蓋内動脈瘤市場：タイプ別

• 動脈閉塞とバイパス
• 血管内コイル塞栓術
• フローダイバータ
• 外科的クリッピング

第7章 頭蓋内動脈瘤市場適応症別

• 破裂した動脈瘤
• 未破裂動脈瘤

第8章 頭蓋内動脈瘤市場：エンドユーザー別

• クリニック
• 病院

第9章 南北アメリカの頭蓋内動脈瘤市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の頭蓋内動脈瘤市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの頭蓋内動脈瘤市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • エヴァスクは臨床マイルストーンを発表し、ドイツの子会社とともに欧州でのプレゼンスを拡大する計画を発表
  • OUの研究者が脳動脈瘤の治療を改善するデバイスを設計

企業一覧

• Adeor Medical AG
• Oxford Endovascular Ltd.
• F. Hoffmann-La Roche AG
• Mizuho Medical Co,Ltd.
• Penumbra, Inc.
• Acandis GmbH
• Medtronic PLC
• Abbott Laboratories
• Integra Lifesciences Holdings Corporation
• B. Braun Melsungen AG
• Cardiatis, S.A.
• Johnson & Johnson Services, Inc.
• Bristol-Myers Squibb Company
• Pfizer Inc.
• Microport Scientific Corporation
• Evasc Medical Systems Corp
• Balt Extrusion S.A.
• Terumo Corporation
• Abbvie Inc.
• Bayer AG
• Stryker Corporation
• Merck & Co., Inc.
• Kaneka Corporation

LIST OF FIGURES

• FIGURE 1. INTRACRANIAL ANEURYSM MARKET RESEARCH PROCESS
• FIGURE 2. INTRACRANIAL ANEURYSM MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. INTRACRANIAL ANEURYSM MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. INTRACRANIAL ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. INTRACRANIAL ANEURYSM MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. INTRACRANIAL ANEURYSM MARKET DYNAMICS
• TABLE 7. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ARTERY OCCLUSION & BYPASS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ENDOVASCULAR COILING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY SURGICAL CLIPPING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY RUPTURED ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY UNRUPTURED ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 28. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 30. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 47. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 50. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 102. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 112. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 114. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 117. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. INTRACRANIAL ANEURYSM MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. INTRACRANIAL ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2023

The Intracranial Aneurysm Market was valued at USD 1.32 billion in 2023, expected to reach USD 1.60 billion in 2024, and is projected to grow at a CAGR of 22.16%, to USD 5.38 billion by 2030.

Intracranial aneurysms refer to the abnormal dilation of arteries within the brain, posing a significant health risk due to potential rupture, leading to severe complications like hemorrhagic stroke. The increasing incidence of lifestyle-related factors such as hypertension, smoking, and alcoholism drives the necessity for advanced diagnostic and therapeutic solutions. With innovations in neuroimaging technologies and minimally invasive surgical techniques, the intracranial aneurysm market is expanding. The primary applications are in the healthcare sector, particularly in neurodiagnostic centers and hospitals, focusing on endovascular coiling and flow-diverting stents. From an end-use perspective, healthcare providers, research institutions, and device manufacturers represent key stakeholders. Market growth is significantly influenced by technological advancements, increasing healthcare expenditures, and expanding access to healthcare services in emerging economies. Additionally, the aging global population, which experiences a higher prevalence of vascular disorders, presents further growth potential. However, challenges such as high costs of treatment, stringent regulatory approvals, and limited awareness in underdeveloped regions can impede market expansion. To capture emerging opportunities, companies should invest in R&D to develop cost-effective and efficient treatment modalities and partner with medical institutions for clinical trials and educational initiatives. The latest opportunities lie in the rise of AI-driven diagnostic tools and patient-specific treatment planning, which can enhance precision medicine. Nevertheless, economic constraints in low-income regions and high development costs remain significant hurdles. Innovative areas for research include the development of biodegradable stents, enhanced bioinformatics for early detection, and hybrid imaging techniques. The market is predominantly driven by technological advancements and strategic collaborations, thus necessitating a proactive approach in strategic partnerships and continuous innovation to cater to shifting market dynamics and patient needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intracranial Aneurysm Market

The Intracranial Aneurysm Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising Prevalence of Cerebrovascular Disorder due to Changing Lifestyle
  • Inclination for Minimally Invasive Intracranial Aneurysm Procedures
  • Improved Diagnosis for Intracranial Aneurysm
• Market Restraints
  • Side Effects Associated with Therapies and High Cost of Treatments
• Market Opportunities
  • Rise in Research and Development Activities and Introduction of Innovative Technology Products
  • Rising Potential for Endovascular Coiling
• Market Challenges
  • Issues Related to Timing of Surgery and Anesthetic Induction

Porter's Five Forces: A Strategic Tool for Navigating the Intracranial Aneurysm Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intracranial Aneurysm Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intracranial Aneurysm Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intracranial Aneurysm Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intracranial Aneurysm Market

A detailed market share analysis in the Intracranial Aneurysm Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intracranial Aneurysm Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intracranial Aneurysm Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Intracranial Aneurysm Market, highlighting leading vendors and their innovative profiles. These include Adeor Medical AG, Oxford Endovascular Ltd., F. Hoffmann-La Roche AG, Mizuho Medical Co,Ltd., Penumbra, Inc., Acandis GmbH, Medtronic PLC, Abbott Laboratories, Integra Lifesciences Holdings Corporation, B. Braun Melsungen AG, Cardiatis, S.A., Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company, Pfizer Inc., Microport Scientific Corporation, Evasc Medical Systems Corp, Balt Extrusion S.A., Terumo Corporation, Abbvie Inc., Bayer AG, Stryker Corporation, Merck & Co., Inc., and Kaneka Corporation.

Market Segmentation & Coverage

This research report categorizes the Intracranial Aneurysm Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Artery Occlusion & Bypass, Endovascular Coiling, Flow Diverters, and Surgical Clipping.
• Based on Indication, market is studied across Ruptured Aneurysm and Unruptured Aneurysm.
• Based on End User, market is studied across Clinics and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising Prevalence of Cerebrovascular Disorder due to Changing Lifestyle
    • 5.1.1.2. Inclination for Minimally Invasive Intracranial Aneurysm Procedures
    • 5.1.1.3. Improved Diagnosis for Intracranial Aneurysm
  • 5.1.2. Restraints
    • 5.1.2.1. Side Effects Associated with Therapies and High Cost of Treatments
  • 5.1.3. Opportunities
    • 5.1.3.1. Rise in Research and Development Activities and Introduction of Innovative Technology Products
    • 5.1.3.2. Rising Potential for Endovascular Coiling
  • 5.1.4. Challenges
    • 5.1.4.1. Issues Related to Timing of Surgery and Anesthetic Induction
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Demand for minimally invasive technique such as endovascular coiling for smaller, saccular aneurysms
  • 5.2.2. End User: Rising patient flow across clinics for early screening and diagnostic services
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Intracranial Aneurysm Market, by Type

• 6.1. Introduction
• 6.2. Artery Occlusion & Bypass
• 6.3. Endovascular Coiling
• 6.4. Flow Diverters
• 6.5. Surgical Clipping

7. Intracranial Aneurysm Market, by Indication

• 7.1. Introduction
• 7.2. Ruptured Aneurysm
• 7.3. Unruptured Aneurysm

8. Intracranial Aneurysm Market, by End User

• 8.1. Introduction
• 8.2. Clinics
• 8.3. Hospitals

9. Americas Intracranial Aneurysm Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Intracranial Aneurysm Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Intracranial Aneurysm Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Evasc announces clinical milestones and plans to expand European presence with German subsidiary
  • 12.3.2. OU Researchers Designing Device to Improve Brain Aneurysm Treatment

Companies Mentioned

• 1. Adeor Medical AG
• 2. Oxford Endovascular Ltd.
• 3. F. Hoffmann-La Roche AG
• 4. Mizuho Medical Co,Ltd.
• 5. Penumbra, Inc.
• 6. Acandis GmbH
• 7. Medtronic PLC
• 8. Abbott Laboratories
• 9. Integra Lifesciences Holdings Corporation
• 10. B. Braun Melsungen AG
• 11. Cardiatis, S.A.
• 12. Johnson & Johnson Services, Inc.
• 13. Bristol-Myers Squibb Company
• 14. Pfizer Inc.
• 15. Microport Scientific Corporation
• 16. Evasc Medical Systems Corp
• 17. Balt Extrusion S.A.
• 18. Terumo Corporation
• 19. Abbvie Inc.
• 20. Bayer AG
• 21. Stryker Corporation
• 22. Merck & Co., Inc.
• 23. Kaneka Corporation